Prostate Cancer With OligometaSTatic Relapse: Combining Stereotactic Ablative Radiotherapy and Durvalumab (MEDI4736)

Clinical trial NCT03795207 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03795207
Sponsor: Institut Cancerologie de l'Ouest
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Node; Prostate Bone Metastases Prostate Cancer Patients

Start date: 2019-03-21
Primary completion: 2023-12-27
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.